世界の院内感染症検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hospital-Acquired Disease Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2919 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、院内感染症検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（UTI検査、SSI検査、肺炎球菌感染症検査、菌血症検査、MRSA検査）、用途別市場規模（中・小規模病院、大規模病院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・院内感染症検査の市場動向 ・企業の競争状況、市場シェア ・院内感染症検査の種類別市場規模（UTI検査、SSI検査、肺炎球菌感染症検査、菌血症検査、MRSA検査） ・院内感染症検査の用途別市場規模（中・小規模病院、大規模病院） ・院内感染症検査の北米市場規模2016-2027（アメリカ、カナダ） ・院内感染症検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・院内感染症検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・院内感染症検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・院内感染症検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Diatherix Laboratories、Gen-Probe、Qiagen、F. Hoffmann-La Roche、Cepheid、Life Technologies Corporation、Meridian Biosciences、Cantel Medical Corporation、Nordion） ・結論

Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
The increasing incidence of hospital acquired infections (HAI) is one of the key factors propelling the global hospital acquired disease testing market. For the prevention of these infections many countries such as the U.S. have issued rules and regulations to be mounted in the hospitals and clinics. For instance, the U.S. has regulated HHS Action Plan to reduce infections auqired in hospitals. These government plans and movements and increasing investments are expected to poise to growth of the global market of hospital acquired disease testing. Furthermore, the rising number of pathogens with drug-resistant abilities is foreseen to help the market expand. Numerous hospitals around the world are facilitating the pathogen detection procedures with improved surveillance culture. To prevent the transmission of diseases, various health organizations are demanding for effective hospital acquired disease testing solutions.

Market Analysis and Insights: Global Hospital-Acquired Disease Testing Market
The global Hospital-Acquired Disease Testing market size is projected to reach US$ 706.1 million by 2026, from US$ 492.3 million in 2019, at a CAGR of 5.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital-Acquired Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital-Acquired Disease Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital-Acquired Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital-Acquired Disease Testing market.

Global Hospital-Acquired Disease Testing Scope and Market Size
Hospital-Acquired Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital-Acquired Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
UTI Testing
SSI Testing
Pneumococcal Infections Testing
Bloodstream Infections Testing
MRSA Testing

Segment by Application
Small and Medium Sized Hospitals
Large Sized Hospitals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Diatherix Laboratories
Gen-Probe
Qiagen
F. Hoffmann-La Roche
Cepheid
Life Technologies Corporation
Meridian Biosciences
Cantel Medical Corporation
Nordion

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 UTI Testing
1.2.3 SSI Testing
1.2.4 Pneumococcal Infections Testing
1.2.5 Bloodstream Infections Testing
1.2.6 MRSA Testing
1.3 Market by Application
1.3.1 Global Hospital-Acquired Disease Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Small and Medium Sized Hospitals
1.3.3 Large Sized Hospitals
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hospital-Acquired Disease Testing Market Perspective (2016-2027)
2.2 Hospital-Acquired Disease Testing Growth Trends by Regions
2.2.1 Hospital-Acquired Disease Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hospital-Acquired Disease Testing Historic Market Share by Regions (2016-2021)
2.2.3 Hospital-Acquired Disease Testing Forecasted Market Size by Regions (2022-2027)
2.3 Hospital-Acquired Disease Testing Industry Dynamic
2.3.1 Hospital-Acquired Disease Testing Market Trends
2.3.2 Hospital-Acquired Disease Testing Market Drivers
2.3.3 Hospital-Acquired Disease Testing Market Challenges
2.3.4 Hospital-Acquired Disease Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Disease Testing Players by Revenue
3.1.1 Global Top Hospital-Acquired Disease Testing Players by Revenue (2016-2021)
3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2016-2021)
3.2 Global Hospital-Acquired Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Disease Testing Revenue
3.4 Global Hospital-Acquired Disease Testing Market Concentration Ratio
3.4.1 Global Hospital-Acquired Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Disease Testing Revenue in 2020
3.5 Hospital-Acquired Disease Testing Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Disease Testing Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-Acquired Disease Testing Breakdown Data by Type
4.1 Global Hospital-Acquired Disease Testing Historic Market Size by Type (2016-2021)
4.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2022-2027)

5 Hospital-Acquired Disease Testing Breakdown Data by Application
5.1 Global Hospital-Acquired Disease Testing Historic Market Size by Application (2016-2021)
5.2 Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hospital-Acquired Disease Testing Market Size (2016-2027)
6.2 North America Hospital-Acquired Disease Testing Market Size by Type
6.2.1 North America Hospital-Acquired Disease Testing Market Size by Type (2016-2021)
6.2.2 North America Hospital-Acquired Disease Testing Market Size by Type (2022-2027)
6.2.3 North America Hospital-Acquired Disease Testing Market Size by Type (2016-2027)
6.3 North America Hospital-Acquired Disease Testing Market Size by Application
6.3.1 North America Hospital-Acquired Disease Testing Market Size by Application (2016-2021)
6.3.2 North America Hospital-Acquired Disease Testing Market Size by Application (2022-2027)
6.3.3 North America Hospital-Acquired Disease Testing Market Size by Application (2016-2027)
6.4 North America Hospital-Acquired Disease Testing Market Size by Country
6.4.1 North America Hospital-Acquired Disease Testing Market Size by Country (2016-2021)
6.4.2 North America Hospital-Acquired Disease Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hospital-Acquired Disease Testing Market Size (2016-2027)
7.2 Europe Hospital-Acquired Disease Testing Market Size by Type
7.2.1 Europe Hospital-Acquired Disease Testing Market Size by Type (2016-2021)
7.2.2 Europe Hospital-Acquired Disease Testing Market Size by Type (2022-2027)
7.2.3 Europe Hospital-Acquired Disease Testing Market Size by Type (2016-2027)
7.3 Europe Hospital-Acquired Disease Testing Market Size by Application
7.3.1 Europe Hospital-Acquired Disease Testing Market Size by Application (2016-2021)
7.3.2 Europe Hospital-Acquired Disease Testing Market Size by Application (2022-2027)
7.3.3 Europe Hospital-Acquired Disease Testing Market Size by Application (2016-2027)
7.4 Europe Hospital-Acquired Disease Testing Market Size by Country
7.4.1 Europe Hospital-Acquired Disease Testing Market Size by Country (2016-2021)
7.4.2 Europe Hospital-Acquired Disease Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size (2016-2027)
8.2 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Type
8.2.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Application
8.3.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region
8.4.1 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hospital-Acquired Disease Testing Market Size (2016-2027)
9.2 Latin America Hospital-Acquired Disease Testing Market Size by Type
9.2.1 Latin America Hospital-Acquired Disease Testing Market Size by Type (2016-2021)
9.2.2 Latin America Hospital-Acquired Disease Testing Market Size by Type (2022-2027)
9.2.3 Latin America Hospital-Acquired Disease Testing Market Size by Type (2016-2027)
9.3 Latin America Hospital-Acquired Disease Testing Market Size by Application
9.3.1 Latin America Hospital-Acquired Disease Testing Market Size by Application (2016-2021)
9.3.2 Latin America Hospital-Acquired Disease Testing Market Size by Application (2022-2027)
9.3.3 Latin America Hospital-Acquired Disease Testing Market Size by Application (2016-2027)
9.4 Latin America Hospital-Acquired Disease Testing Market Size by Country
9.4.1 Latin America Hospital-Acquired Disease Testing Market Size by Country (2016-2021)
9.4.2 Latin America Hospital-Acquired Disease Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size (2016-2027)
10.2 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type
10.2.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application
10.3.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country
10.4.1 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Diatherix Laboratories
11.1.1 Diatherix Laboratories Company Details
11.1.2 Diatherix Laboratories Business Overview
11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Introduction
11.1.4 Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.1.5 Diatherix Laboratories Recent Development
11.2 Gen-Probe
11.2.1 Gen-Probe Company Details
11.2.2 Gen-Probe Business Overview
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Introduction
11.2.4 Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.2.5 Gen-Probe Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Hospital-Acquired Disease Testing Introduction
11.3.4 Qiagen Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.3.5 Qiagen Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Cepheid
11.5.1 Cepheid Company Details
11.5.2 Cepheid Business Overview
11.5.3 Cepheid Hospital-Acquired Disease Testing Introduction
11.5.4 Cepheid Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.5.5 Cepheid Recent Development
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Details
11.6.2 Life Technologies Corporation Business Overview
11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Introduction
11.6.4 Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.6.5 Life Technologies Corporation Recent Development
11.7 Meridian Biosciences
11.7.1 Meridian Biosciences Company Details
11.7.2 Meridian Biosciences Business Overview
11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Introduction
11.7.4 Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.7.5 Meridian Biosciences Recent Development
11.8 Cantel Medical Corporation
11.8.1 Cantel Medical Corporation Company Details
11.8.2 Cantel Medical Corporation Business Overview
11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Introduction
11.8.4 Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.8.5 Cantel Medical Corporation Recent Development
11.9 Nordion
11.9.1 Nordion Company Details
11.9.2 Nordion Business Overview
11.9.3 Nordion Hospital-Acquired Disease Testing Introduction
11.9.4 Nordion Revenue in Hospital-Acquired Disease Testing Business (2016-2021)
11.9.5 Nordion Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hospital-Acquired Disease Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of UTI Testing
Table 3. Key Players of SSI Testing
Table 4. Key Players of Pneumococcal Infections Testing
Table 5. Key Players of Bloodstream Infections Testing
Table 6. Key Players of MRSA Testing
Table 7. Global Hospital-Acquired Disease Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hospital-Acquired Disease Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hospital-Acquired Disease Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Hospital-Acquired Disease Testing Market Share by Regions (2016-2021)
Table 11. Global Hospital-Acquired Disease Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Hospital-Acquired Disease Testing Market Share by Regions (2022-2027)
Table 13. Hospital-Acquired Disease Testing Market Trends
Table 14. Hospital-Acquired Disease Testing Market Drivers
Table 15. Hospital-Acquired Disease Testing Market Challenges
Table 16. Hospital-Acquired Disease Testing Market Restraints
Table 17. Global Hospital-Acquired Disease Testing Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Hospital-Acquired Disease Testing Market Share by Players (2016-2021)
Table 19. Global Top Hospital-Acquired Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Disease Testing as of 2020)
Table 20. Ranking of Global Top Hospital-Acquired Disease Testing Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Hospital-Acquired Disease Testing Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hospital-Acquired Disease Testing Product Solution and Service
Table 24. Date of Enter into Hospital-Acquired Disease Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hospital-Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2016-2021)
Table 28. Global Hospital-Acquired Disease Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Hospital-Acquired Disease Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Hospital-Acquired Disease Testing Revenue Market Share by Application (2016-2021)
Table 32. Global Hospital-Acquired Disease Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Hospital-Acquired Disease Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Hospital-Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Hospital-Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Hospital-Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Hospital-Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Hospital-Acquired Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Hospital-Acquired Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Hospital-Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Hospital-Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Hospital-Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Hospital-Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Hospital-Acquired Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Hospital-Acquired Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Hospital-Acquired Disease Testing Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Hospital-Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Hospital-Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Hospital-Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Hospital-Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Hospital-Acquired Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Hospital-Acquired Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Country (2022-2027) & (US$ Million)
Table 64. Diatherix Laboratories Company Details
Table 65. Diatherix Laboratories Business Overview
Table 66. Diatherix Laboratories Hospital-Acquired Disease Testing Product
Table 67. Diatherix Laboratories Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 68. Diatherix Laboratories Recent Development
Table 69. Gen-Probe Company Details
Table 70. Gen-Probe Business Overview
Table 71. Gen-Probe Hospital-Acquired Disease Testing Product
Table 72. Gen-Probe Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 73. Gen-Probe Recent Development
Table 74. Qiagen Company Details
Table 75. Qiagen Business Overview
Table 76. Qiagen Hospital-Acquired Disease Testing Product
Table 77. Qiagen Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 78. Qiagen Recent Development
Table 79. F. Hoffmann-La Roche Company Details
Table 80. F. Hoffmann-La Roche Business Overview
Table 81. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product
Table 82. F. Hoffmann-La Roche Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 83. F. Hoffmann-La Roche Recent Development
Table 84. Cepheid Company Details
Table 85. Cepheid Business Overview
Table 86. Cepheid Hospital-Acquired Disease Testing Product
Table 87. Cepheid Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 88. Cepheid Recent Development
Table 89. Life Technologies Corporation Company Details
Table 90. Life Technologies Corporation Business Overview
Table 91. Life Technologies Corporation Hospital-Acquired Disease Testing Product
Table 92. Life Technologies Corporation Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 93. Life Technologies Corporation Recent Development
Table 94. Meridian Biosciences Company Details
Table 95. Meridian Biosciences Business Overview
Table 96. Meridian Biosciences Hospital-Acquired Disease Testing Product
Table 97. Meridian Biosciences Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 98. Meridian Biosciences Recent Development
Table 99. Cantel Medical Corporation Company Details
Table 100. Cantel Medical Corporation Business Overview
Table 101. Cantel Medical Corporation Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 102. Cantel Medical Corporation Recent Development
Table 103. Nordion Company Details
Table 104. Nordion Business Overview
Table 105. Nordion Hospital-Acquired Disease Testing Product
Table 106. Nordion Revenue in Hospital-Acquired Disease Testing Business (2016-2021) & (US$ Million)
Table 107. Nordion Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Acquired Disease Testing Market Share by Type: 2020 VS 2027
Figure 2. UTI Testing Features
Figure 3. SSI Testing Features
Figure 4. Pneumococcal Infections Testing Features
Figure 5. Bloodstream Infections Testing Features
Figure 6. MRSA Testing Features
Figure 7. Global Hospital-Acquired Disease Testing Market Share by Application: 2020 VS 2027
Figure 8. Small and Medium Sized Hospitals Case Studies
Figure 9. Large Sized Hospitals Case Studies
Figure 10. Hospital-Acquired Disease Testing Report Years Considered
Figure 11. Global Hospital-Acquired Disease Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Hospital-Acquired Disease Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hospital-Acquired Disease Testing Market Share by Regions: 2020 VS 2027
Figure 14. Global Hospital-Acquired Disease Testing Market Share by Regions (2022-2027)
Figure 15. Global Hospital-Acquired Disease Testing Market Share by Players in 2020
Figure 16. Global Top Hospital-Acquired Disease Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital-Acquired Disease Testing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Hospital-Acquired Disease Testing Revenue in 2020
Figure 18. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2016-2021)
Figure 19. Global Hospital-Acquired Disease Testing Revenue Market Share by Type (2022-2027)
Figure 20. North America Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Hospital-Acquired Disease Testing Market Share by Type (2016-2027)
Figure 22. North America Hospital-Acquired Disease Testing Market Share by Application (2016-2027)
Figure 23. North America Hospital-Acquired Disease Testing Market Share by Country (2016-2027)
Figure 24. United States Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hospital-Acquired Disease Testing Market Share by Type (2016-2027)
Figure 28. Europe Hospital-Acquired Disease Testing Market Share by Application (2016-2027)
Figure 29. Europe Hospital-Acquired Disease Testing Market Share by Country (2016-2027)
Figure 30. Germany Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hospital-Acquired Disease Testing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Hospital-Acquired Disease Testing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Hospital-Acquired Disease Testing Market Share by Region (2016-2027)
Figure 40. China Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hospital-Acquired Disease Testing Market Share by Type (2016-2027)
Figure 48. Latin America Hospital-Acquired Disease Testing Market Share by Application (2016-2027)
Figure 49. Latin America Hospital-Acquired Disease Testing Market Share by Country (2016-2027)
Figure 50. Mexico Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hospital-Acquired Disease Testing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Hospital-Acquired Disease Testing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Hospital-Acquired Disease Testing Market Share by Country (2016-2027)
Figure 56. Turkey Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Hospital-Acquired Disease Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Diatherix Laboratories Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 60. Gen-Probe Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 61. Qiagen Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 63. Cepheid Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 64. Life Technologies Corporation Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 65. Meridian Biosciences Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 66. Cantel Medical Corporation Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 67. Nordion Revenue Growth Rate in Hospital-Acquired Disease Testing Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---